The effect of fluticasone propionate aqueous nasal spray on eosinophils and cytokines in nasal secretions of patients with ragweed allergic rhinitis

Clinical Therapeutics

Volumn 19, Issue 2, 1997, Pages 273-281

  Alvarado Valdés, Carlos A ^a   Blomgren, Judith ^b   Weiler, Deborah ^b   Gleich, Gerald J ^b   Reed, Charles E ^b   Field, Elizabeth A ^c   Wisniewski, Michael E ^c   Pobiner, Bonnie F ^c  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

allergic rhinitis; astemizole; cytokines; eosinophils; fluticasone propionate; glucocorticoid

Indexed keywords

ASTEMIZOLE; CYTOKINE; FLUTICASONE PROPIONATE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 5; NEUROTOXIN; NOSE SPRAY;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; LAVAGE; MALE; NOSE SECRETION; RANDOMIZED CONTROLLED TRIAL;

EID: 0030950378     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(97)80115-4     Document Type: Article

References (30)

1. Corrigan CJ, Brown PH, Barnes NC, et al. Glucocorticoid resistance in chronic asthma, glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis. 1991;144:1016-1025.
2. Schleimer RP. An overview of glucocorticoid antiinflammatory actions. Eur J Clin Pharmacol. 1993;45(Suppl 1):S3-S7.
3. Wallen N, Kita H, Weiler D, Gleich GJ. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol. 1991;147: 3490-3495.
4. Meltzer EO, Orgel HA, Bronsky EA, et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology. J Allergy Clin Immunol. 1990;86: 221-230.
5. Bryson HM, Faulds D. Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs. 1992;43:760-775.
6. Ratner PH, Paull BR, Findlay SR, et al. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily. J Allergy Clin Immunol. 1992; 90:285-291.
7. Handing SM. The human pharmacology of fluticasone propionate. Respir Med. 1990;84(Suppl A):25-29.
8. Meltzer EO, Orgel HA, Rogenes PR, Field EA. Nasal cytology in patients with allergic rhinitis: Effects of intranasal fluticasone propionate. J Allergy Clin Immunol. 1994;94:708-715.
9. Gleich GJ, Adolphson CR, Leifermon KM. The biology of the eosinophilic leukocyte. Annu Rev Med. 1993;44:85-101.
10. Pelikan Z. The changes in the nasal secretions of eosinophils during the immediate nasal response to allergen challenge. J Allergy Clin Immunol. 1983;72:657-662.
11. Reed CS, Bubach M, Dunnette S, et al. Ragweed specific IgA in nasal lavage fluid of ragweed-sensitive allergic rhinitis patients. Int Arch Allergy Immunol. 1991; 94:275-277.
12. Gleich GJ, Adolphson CR, Leferman KM. Eosinophils. In: Galin NI, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. 2nd ed. New York: Raven Press; 1992:663-700.
13. Diukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis. 1990;142:434-457.
14. Broide DH, Lotz M, Cuomo AJ, et al. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol. 1992;89:958-967.
15. Weller PF. Cytokine regulation of eosinophil function. Clin Immunol Immunopathol. 1992;62(Suppl 1, Pt 2): S55-S59.
16. Wang JM, Rambaldi A, Blondi A, et al. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol. 1989;19:701-705.
17. Linder A. Symptom scores as measures of the severity of rhinitis. Clin Allergy. 1988; 18:29-37.
18. Pipkorn U, Karlsson G. Methods for obtaining specimens from the nasal mucosa for morphological and biochemical analysis. Eur Respir J. 1988;1:856-862.
19. Ide M, Weiler D, Kita H, et al. Ammonium chloride exposure inhibits cytokinemediated eosinophil survival. J Immunol Methods. 1994;168:187-196.
20. Ohnushi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis. 1993;147:901-907.
21. van Bavel J, Findlay S, Hampel F, et al. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med. 1994;154:2699-2704.
22. Broide DH, Firestein GS. Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization. J Clin Invest. 1992;88:1048-1053.
23. Metzger WJ, Richerson HB, Wasserman SI. Generation and partial characterization of eosinophilic chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic response. J Allergy Clin Immunol. 1986; 78:282-290.
24. Kay AB, Ying S, Varney A, et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med. 1991;173:775-778.
25. Cox G, Ohtoshi T, Vancheri C, et al. Promotion of eosinophil survival by human bronchial endothelial cells and its modulation by steroids. Am J Respir Cell Mol Biol. 1991;4:525-531.
26. Marini M, Vitori E, Hollinborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte macrophage colony stimulating factor and interleukin in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol. 1992;89:1001-1009.
27. Sousa AR, Poston RN, Lane SJ, et al. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis. 1993;147: 1557-1561.
28. Dubucquoi S, Desreumaux P, Janin A, et al. Interleukin-5 synthesis by eosinophil: Association with granules and immunoglobulin-dependent secretion. J Exp Med. 1994;179:703-708.
29. Meltzer E, Jalowayski A, Field E, et al. Intranasal fluticasone propionate reduces histamine and tryptase in the mucosa of allergic rhinitis patients. J Allergy Clin Immunol. 1993;91:298. Abstract.
30. Kita H, Abu-Ghagaleh R, Sanderson CJ, Gleich GJ. Effect of steroids on immunoglobulin-induced eosinophil degranulation. J Allergy Clin Immunol. 1991; 8:70-77.